Faculty

Sascha Dublin

Affiliate Professor, Epidemiology

206-287-2870

Education

PhD Epidemiology, University of Washington, 1999
MD University of Washington, 2001

Contact

206-287-2870

Kaiser Permanente Washington Health Research Institute
1730 Minor Avenue, Suite 1600
Seattle, WA 98101

Research Interests

Dr. Dublin’s research interests include pharmacoepidemiology, pregnancy outcomes and perinatal epidemiology; aging; and cardiovascular epidemiology. Her work uses real-world health care data from Group Health and many other sources to better understand the safety and effectiveness of medications and other medical interventions.  She often focuses on the impact of interventions in vulnerable populations, particularly pregnant women and older adults. She also has interest and expertise in using novel statistical and epidemiologic methods to answer real-world questions, such as the use of two-phase study designs to reduce bias and Natural Language Processing  to extract information from electronic medical records (EMRs).  She is the Group Health site Principal Investigator for the Medication Exposures in Pregnancy Risk Evaluation Program (MEPREP), a multisite collaboration that has developed data sets including 1.2 million pregnancies across 11 health plans to examine medication safety in pregnant women.

Recent Publications (PubMed)

Corrigendum to "Survey on the use of patient contact shielding during radiological practice: The European radiographers' perspective" [Radiography (2026) 32(1) 103241].
(2026 Sep 30)
Radiography (Lond)
Federico L, Roletto A, Manzo L, Canulli L, Nieri I, Panci S, Catania D, Rainford L, Gerasia R

Hereditary spastic paraplegia: a practical approach.
(2026 Sep 30)
Pract Neurol
Bradley M, Kalfat A, Walsh RA, Lynch T, Fearon C, Houlden H

Anakinra versus intramuscular methylprednisolone acetate for gout flares in people with chronic kidney disease (ASGARD): a UK randomised multicentre, double-blind, double-dummy controlled feasibility study with economic, qualitative and safety assessment.
(2026 Sep 30)
BMJ Open 16(9): e114454
Balasubramaniam G, Almond M, Harnett P, Turner D, Scales J, Zhang J, Moore C, Hayden K, Roddy E, Mallen C, Stack J, Bhagat S, Ng N, Rutherford A, Dasgupta B

Energy-Based Devices: Their Irreplaceable Role in Modern Facelifting.
(2026 Nov)
Facial Plast Surg Clin North Am 34(4): 527-547
Gentile RD

Beyond endothelial cells: mutant p53 drives de novo von Willebrand factor expression.
(2026 Oct)
J Thromb Haemost 24(10): 3440-3442
Ünlü B, O'Sullivan JM

Show complete publication list

In the News